IMDELLTRA 10 MG Injection

RxCUI: 2682971
RxNorm name: IMDELLTRA 10 MG Injection
Display name: IMDELLTRA 10 MG Injection
Full name: IMDELLTRA 10 MG Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:50

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761344	Imdelltra	tarlatamab-dlle	351(a)	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
IMDELLTRA (AMG757)	TARLATAMAB-DLLE	Amgen, Inc	1e7b6163-5d83-42ea-82c9-cf7620cdc782	2026-06-23	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2682971

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
1e7b6163-5d83-42ea-82c9-cf7620cdc782	IMDELLTRA 10 MG Injection	PSN	5	These highlights do not include all the information needed to use IMDELLTRA ® safely and effectively. See full prescribing information for IMDELLTRA. IMDELLTRA ® (tarlatamab-dlle) for injection, for intravenous use Initial U.S. Approval: 2024	20251119
1e7b6163-5d83-42ea-82c9-cf7620cdc782	Imdelltra 10 MG Injection	SY	5	These highlights do not include all the information needed to use IMDELLTRA ® safely and effectively. See full prescribing information for IMDELLTRA. IMDELLTRA ® (tarlatamab-dlle) for injection, for intravenous use Initial U.S. Approval: 2024	20251119
1e7b6163-5d83-42ea-82c9-cf7620cdc782	tarlatamab-dlle 10 MG Injection [Imdelltra]	SBD	5	These highlights do not include all the information needed to use IMDELLTRA ® safely and effectively. See full prescribing information for IMDELLTRA. IMDELLTRA ® (tarlatamab-dlle) for injection, for intravenous use Initial U.S. Approval: 2024	20251119